Life sciences briefing: Wednesday, Jan. 16, 2008
TODAY’S HEADLINES:
Drug-screening tool maker IonGate Bio raises €4.6M (release)
Protein-drug maker Molecular Partners gets $5M up front in Centocor deal (PDF release)
ProtaGen takes in €1M for protein biochips (PDF release)
China’s Sundia MediTech, a contract research organization raises second round (release)
Vital-signs implant maker Transoma Medical sets IPO terms, aims for $78M (Edgar)
UMD receives $1M grant for Baltimore biotech incubator (TechJournal South)
Drug-screening tool maker IonGate Bio raises €4.6M — IonGate Biosciences, a Frankfurt, Germany, developer of tools for… Continue Reading
BioSeek raises $10M from Amylin Pharma for drug screening
BioSeek, a Burlingame, Calif., developer of drug-screening technologies that use human cells, raised $10 million in a third funding round from San Diego-based Amylin Pharmaceuticals. The two companies also formed a partnership in which BioSeek will screen Amylin’s collection of protein fragments, or peptides, to identify possible drugs for treating inflammatory diseases.
As part of that collaboration, BioSeek can select two of Amylin’s peptides for development in diseases outside of Amylin’s own sphere of interest. The… Continue Reading